TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients

BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients.

It is estimated that one in a hundred patients may be transgender, therefore it is important for healthcare professionals to be able to provide inclusive care with safe and effective prescribing.

BOPA and OUTpatients came together to develop this world first resource that guides and supports healthcare professionals while caring for their transgender patients.

The document is available via here.

 

Latest News

By BOPA Digital Subcommittee on 10th January 2025

BOPA Digital Subcommittee – new members required

The BOPA digital subcommittee are looking for new members. The primary purpose of the BOPA digital subcommittee is to promote excellence in the pharmaceutical care of patients by supporting membership…

Read article
By BOPA Education & Training Subcommittee on 8th January 2025

Opportunity for a pharmacist to review the eLearning content for Chronic Lymphocytic Leukaemia

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist to review…

Read article
By BOPA Passport pillar on 8th January 2025

Request for membership to create or review content for BOPA Digital SACT passport

Dear Member, In order to optimise the user experience of the BOPA SACT Verification Passport, we need to have new and relevant content. The Passport working group would like to…

Read article
By BOPA Committee on 8th January 2025

BOPA Podcast – Let’s Talk About The Future of Healthcare

The next episode of Let’s Talk About SACT is Let’s talk about the future of Healthcare. In this episode we are joined by Julian Barwell. We discuss predictions for what…

Read article